Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster session 17

1343P - NCRI’s Consumer Forum: Patients promoting evidence-based medicine and evidence-based policy

Date

10 Sep 2022

Session

Poster session 17

Topics

Patient Education and Advocacy;  Translational Research

Tumour Site

Presenters

Emma Kinloch

Citation

Annals of Oncology (2022) 33 (suppl_7): S600-S615. 10.1016/annonc/annonc1069

Authors

E. Kinloch1, R.K. Stephens2

Author affiliations

  • 1 Consumer Forum, NCRI - National Cancer Research Institute, E20 1JQ - London/GB
  • 2 Consumer Forum, National Cancer Research Institute, E20 1jq - London/GB

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 1343P

Background

Since its inception in 2000 the UK’s National Cancer Research Institute (‘NCRI’) has committed to involve Consumers (patents and public) representatives in all aspects of its work.

Methods

Consumers are recruited in open competition, trained for specific NCRI roles, and supported to work beyond those roles. The NCRI Consumer Forum contains 140 members from all four UK nations, providing a pool of experienced advocates working in all areas of cancer research. The membership reflects the geographic diversity of the four UK nations.

Results

75% of Consumers work with research funders or organisations outside the NCRI Partners. In the 2021 census, more than 50 such organisations were identified, including local, national and international organisations, charities, NHS Trusts, online communities and patient groups. Consumers work or have worked with industry including Big Pharma, biotechs and medical device manufacturers. They serve on Trial Management/Steering Groups, sit on research funding committees and hold governance or accountability posts, eg Board members, Charity Trustees, NHS Commissioners. All have worked on patient information, including websites, videos and audio. During the COVID-19 pandemic in 2020-21 the Consumer Forum worked collaboratively with the UK Coronavirus Cancer Monitoring Project to create, distribute and analyse a survey asking cancer patients what was important to them for COVID-19 and cancer research. Results informed the direction of Covid-19 and cancer research in the UK. This collaboration continued with regular discussion around new research areas and collaboration on peer-reviewed journal articles. Consumers work/have worked with strategic bodies in the UK and beyond eg NICE, MHRA, HRA, BBMRI-ERIC, EORTC. Consumers have provided responses to two recent UK Government consultations, inputting into the strategy of the UK regulatory environment via the MHRA clinical trials regulation and shaping the future strategy for cancer care and research via the national 10-year cancer plan.

Conclusions

The NCRI Consumer Forum is a group of Patients and Carers promoting evidence-based medicine and evidence-based policy in the UK and beyond.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

NCRI.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.